Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04347200 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REGistry of Long-term AnTithrombotic TherApy-1

Study acronym: REGATTA-1
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Jan 31, 2026 to Dec 31, 2026v3
  2. Primary and study completion dates: Dec 31, 2025 to Jan 31, 2026
    • Publications: 6 to 9
    • Eligibility criteria expanded, about 4 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes
Trial Details
NCT Number NCT04347200
Lead Sponsor National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Conditions
(from sponsor)		 Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease
Related terms Angina Pectoris, Coronary Artery Disease, Myocardial Infarction, Peripheral Arterial Disease
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov